Nicholas Erho
Nicholas Erho
Research Science Manager, Amazon Alexa
Verified email at
Cited by
Cited by
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ...
Nature genetics 45 (11), 1392-1398, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ...
PloS one 8 (6), e66855, 2013
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ...
Nature communications 5 (1), 5383, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population
RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ...
The Journal of urology 190 (6), 2047-2053, 2013
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ...
The lancet oncology 15 (13), 1469-1480, 2014
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men
AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ...
European urology 69 (1), 157-165, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, H Al-deen Ashab, ...
Cancer research 76 (17), 4948-4958, 2016
The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target
SG Zhao, J Lehrer, SL Chang, R Das, N Erho, Y Liu, M Sjöström, RB Den, ...
JNCI: Journal of the National Cancer Institute 111 (3), 301-310, 2019
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes
SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ...
European urology 68 (4), 555-567, 2015
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
AE Ross, FY Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, ...
Prostate cancer and prostatic diseases 17 (1), 64-69, 2014
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
DP Labbé, G Zadra, M Yang, JM Reyes, CY Lin, S Cacciatore, EM Ebot, ...
Nature communications 10 (1), 4358, 2019
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ...
Prostate cancer and prostatic diseases 20 (1), 28-35, 2017
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ...
EBioMedicine 31, 182-189, 2018
Prostate cancer radiomics and the promise of radiogenomics
R Stoyanova, M Takhar, Y Tschudi, JC Ford, G Solórzano, N Erho, ...
Translational cancer research 5 (4), 432, 2016
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ...
Cell reports 19 (10), 2045-2059, 2017
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
The system can't perform the operation now. Try again later.
Articles 1–20